Gadolinium and nephrogenic systemic fibrosis

Introduction: Gadolinium is a contrast medium used in MRI. Gadolinium compounds differ in their chemical structure. The administration of these compounds has been associated with the emergence of a rare but serious disease called nephrogenic systemic fibrosis, predominantly characterized by skin involvement. Materials and methods: In our center we have three MRI scans of 1.5 T and 3 T MRI and use different gadolinium compounds. Results: This article will discuss the guidelines for the administration of the different compounds of gadolinium. It summarizes the precautions and procedures in different situations. All processes that produce a decrease in glomerular filtration rate and affect renal function, are considered risk factors for the development of nephrogenic systemic fibrosis. Conclusions: Gadolinium is a contrast medium in MRI that provides much information, but we must be aware of its limitations, especially in relation to the nephrogenic systemic fibrosis. Recommendations on the use of gadolinium. Adults: A questionnaire will be used by the technician or radiologist to assess risk factors for kidney failure, and if possible, the glomerular filtration rate is obtained. Children: Information for nursing mothers and parents on the risk of gadolinium and its accumulation. (C) 2012 ACTEDI. Published by Elsevier Espana, S.L. All rights reserved.